Source:http://linkedlifedata.com/resource/pubmed/id/10825762
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2000-7-20
|
pubmed:abstractText |
The purpose of this registry was to document the safety and efficacy of elective deployment of the NIROYAL stent (Boston Scientific SCIMED, Maple Grove, Minnesota) in coronary arteries. This was a prospective, multi-center international registry. NIROYAL stents (9, 16, 25 and 32 mm-long) were manually crimped onto coronary balloons and deployed in de novo or restenotic lesions in 165 male and female patients with angina pectoris and a reference vessel diameter of 2.0-4.5 mm. Stent deployment was successful in 98.8% of the lesions. Mean percent diameter stenosis decreased from 83.5+/-10.8% to 2.7+/- 6.2% after intervention. The interventional procedure of the treatment site was successful in 97.6% of patients. At six-month clinical follow-up, 88.5% had event-free survival [i.e., did not experience a major adverse cardiac event (MACE)] and 95.2% had no anginal symptoms. Furthermore, 87.3% of the patients were free of target vessel failure (defined as a composite of acute procedural failure, target vessel revascularization, myocardial infarction or death at six months). Only three MACE were observed within the first 30 days after stent implantation. A low left ventricular ejection fraction and the percentage stenosis pre-procedure were identified as statistically significant (p<0.05) predictive factors for MACE. The incidences of MACE and target vessel failure after six months follow-up were lower than that seen in other studies, and target lesion revascularization rates were low.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1042-3931
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
225-32
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10825762-Adolescent,
pubmed-meshheading:10825762-Adult,
pubmed-meshheading:10825762-Aged,
pubmed-meshheading:10825762-Angina Pectoris,
pubmed-meshheading:10825762-Angioplasty, Balloon, Coronary,
pubmed-meshheading:10825762-Constriction, Pathologic,
pubmed-meshheading:10825762-Coronary Disease,
pubmed-meshheading:10825762-Equipment Design,
pubmed-meshheading:10825762-Female,
pubmed-meshheading:10825762-Follow-Up Studies,
pubmed-meshheading:10825762-Gold,
pubmed-meshheading:10825762-Humans,
pubmed-meshheading:10825762-International Cooperation,
pubmed-meshheading:10825762-Male,
pubmed-meshheading:10825762-Middle Aged,
pubmed-meshheading:10825762-Multivariate Analysis,
pubmed-meshheading:10825762-Predictive Value of Tests,
pubmed-meshheading:10825762-Probability,
pubmed-meshheading:10825762-Prospective Studies,
pubmed-meshheading:10825762-Recurrence,
pubmed-meshheading:10825762-Registries,
pubmed-meshheading:10825762-Stents,
pubmed-meshheading:10825762-Treatment Outcome
|
pubmed:year |
2000
|
pubmed:articleTitle |
Multicenter registry to evaluate the efficacy of the NIROYAL stent in de novo or restenotic coronary stenosis.
|
pubmed:affiliation |
Villa Maria Cecilia, Cardiology Department, Via Corriera 1, I-48010 Cotignola, Ravenna, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|